Diagens Biotechnology to Showcase World's First High-Efficiency AI-Powered Chromosome Karyotype Precision Diagnostic System on 'Artery New Product Showcase' Episode 90

Chromosome Karyotype AnalysisIt is the gold standard for cytogenetic diagnosis, with clinical applications spanning prenatal diagnosis, assisted reproduction, hematologic oncology diagnosis, and radiation health. Prior to 2019, the global market was monopolized by Leica and Zeiss.Hangzhou Diagens Biotechnology Co., Ltd.(hereinafter referred to as “Diagens”) deeply integrates artificial intelligence technology with medicine, creatingThe World’s First High-Efficiency, Intelligent Equipment for Precise Diagnosis of Chromosome Karyotypes。

This equipment includesCellular Microscopic Image Scanning SystemandAI Karyotyping System, obtainRecognition as the World’s First (Set) and the World’s First Class II NMPA Registration Certificate, reducing the turnaround time for clinical karyotype analysis reports from the original 35 days to 4–7 days, and lowering the labor costs of hospital cytology laboratories to one-tenth of the original level. This equipment has received unanimous endorsement from an expert team led by academicians, who believe thatCore Technologies Are Internationally Leading. Currently, this equipment has been successfully deployed in over 400 Grade A tertiary hospitals,Achieved domestic substitution for Leica and Zeiss。

On Wednesday, August 21, at 19:30, the 87th edition of VCBeat New Product Showcase will feature Li Haibo, Director of the Comprehensive Prevention and Control Center for Birth Defects at Ningbo Women and Children’s Hospital, and Gou Zhengmeng, Chief Marketing Officer of Diagens, presenting “World’s First High-Efficiency Intelligent Equipment for Precise Diagnosis of Chromosome Karyotypes” product sharing.

High-Efficiency Intelligent Equipment for Precise Diagnosis of Chromosome Karyotypes

Scan the QR code on the poster to add our assistant and reserve your spot for the live broadcast.

Li Haibo

Director, Center for Comprehensive Prevention and Control of Birth Defects, Ningbo Women and Children’s Hospital

Visiting Scholar at Harvard Medical School, Zhejiang Province "151" Talent Program Awardee, Member of the Precision Medicine Committee under the China Maternal and Child Health Association, Vice Chair of the Birth Defects Committee under the Zhejiang Maternal and Child Health Association, and Vice Chair of the Young Physicians Committee under the Medical Genetics Branch of the Zhejiang Medical Doctor Association

Gou Zhengmeng

Chief Marketing Officer of Diagens

MBA from CEIBS, with nearly 20 years of in-depth experience in the healthcare industry and extensive industry expertise. Previously served as General Manager of Business Operations at a Fortune 500 healthcare company, among other roles.

Hangzhou Diagens Biotechnology Co., Ltd., established in 2016, is a global leader in medical imaging AI and medical microscopy equipment. Led by multiple national-level experts, Diagens’ R&D, production, and sales teams boast an R&D workforce of which over 50% hold master’s degrees or higher and possess more than ten years of experience in the healthcare industry. The company has spearheaded and participated in numerous national and provincial/ministerial-level research projects, including special projects under the National Key R&D Program. It has developed the world’s largest general-purpose large model for medical imaging by parameter scale and holds over 60 core independent intellectual property rights in China, the United States, Europe, and other regions, covering fields such as prenatal diagnosis, assisted reproduction, hematologic oncology diagnosis, and radiological health.

The Company successfully launched the world’s first AI-based intelligent chromosome analysis system (AutoVision®) and high-precision scanning equipment (MetaSight®), earning certification as the “First Set of International Equipment” from relevant national authorities.

“VCBeat New Product Showcase” is a live-streaming series designed to support healthcare companies in launching their innovative products. The series’ mission is to facilitate the milestone launch of every innovative medical product. Companies with plans to release innovative medical products or achieve significant milestones and wish to participate in the “VCBeat New Product Showcase” are invited to add our assistant for consultation.

Scan the QR code below to contact the assistant and schedule a live stream (if you have already added them, please proactively reach out to the assistant).

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Send a screenshot of the live stream to the assistant to enter the lucky draw for a chance to win a [15-day trial membership to VBInsight Industry Think Tank].